Arch Venture Partners has joined a lineup of top venture groups which has been making hay while the market sun shines on biotech IPOs. The VC has marshaled more than $400 million for its new investment fund–its eighth–that will now be available to back a new wave of cutting-edge life science companies, often starting from scratch.

…read more

Source: Thinking ‘big,’ Arch Venture gathers $400M-plus to back a new wave of biotechs


0 No comments